These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3348237)
1. Nonsteroidal anti-inflammatory drug-induced gastrointestinal damage. Current insights into patient management. Proceedings of a symposium. June 13, 1987, Washington, D.C. Am J Med; 1988 Feb; 84(2A):1-52. PubMed ID: 3348237 [No Abstract] [Full Text] [Related]
2. Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage. McCormack PM Ir Med J; 1994; 87(2):27-8. PubMed ID: 8194941 [No Abstract] [Full Text] [Related]
3. The NSAIDs and the gastrointestinal mucosa. An update symposium. Oslo, 14 October 1988. Proceedings. Scand J Gastroenterol Suppl; 1989; 163():1-73. PubMed ID: 2814362 [No Abstract] [Full Text] [Related]
5. [Nonsteroidal anti-inflammatory agents and gastrointestinal pathology]. Lanas AI Gastroenterol Hepatol; 1995 Mar; 18(3):142-52. PubMed ID: 7621292 [No Abstract] [Full Text] [Related]
6. [Unsolved problems of enteropathy induced by nonsteroidal anti-inflammatory drugs]. Murav'ev IuV; Lebedeva VV Ter Arkh; 2009; 81(2):90-3. PubMed ID: 19334501 [No Abstract] [Full Text] [Related]
7. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
8. New standards in arthritis care. Proceedings of an ILAR symposium. Rio de Janeiro, Brazil, September 18, 1989. J Rheumatol Suppl; 1990 Feb; 20():1-53. PubMed ID: 2325050 [No Abstract] [Full Text] [Related]
9. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use. Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544 [TBL] [Abstract][Full Text] [Related]
10. [Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs]. Shiokawa Y; Nobunaga M; Saito T; Asaki S; Ogawa N Ryumachi; 1991 Feb; 31(1):96-111. PubMed ID: 1858000 [No Abstract] [Full Text] [Related]
11. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy. Russell RI Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464 [TBL] [Abstract][Full Text] [Related]
12. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Sangha S; Oviedo JA Am J Gastroenterol; 2003 May; 98(5):1203-4; author reply 1204. PubMed ID: 12809852 [No Abstract] [Full Text] [Related]
13. [Gastrointestinal damage in osteoarthritis patients]. Fuller R; Hirose-Pastor E; Levy M; Zaterka S; Massuda HB; Eisig JN; Yoshinari NH Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):47-50. PubMed ID: 9435394 [TBL] [Abstract][Full Text] [Related]
14. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage. Lisotti A; Grenci C; Caponi A; Roda E Minerva Gastroenterol Dietol; 2008 Dec; 54(4):323-9. PubMed ID: 19047972 [No Abstract] [Full Text] [Related]
15. Prevalence of upper gastrointestinal lesions in patients taking chronic nonsteroidal anti-inflammatory drug therapy. Zuckerman MJ; Hernández JA; Marwah RK; Pema KM; Gupta TP; al-Samman M Am J Gastroenterol; 1997 Feb; 92(2):363-4. PubMed ID: 9040233 [No Abstract] [Full Text] [Related]
17. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects. Eliakim R; Rachmilewitz D Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147 [No Abstract] [Full Text] [Related]
18. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment]. Martín de Argila C; Moreira V; Gisbert JP An Med Interna; 1995 Feb; 12(2):85-96. PubMed ID: 7749017 [TBL] [Abstract][Full Text] [Related]